Nurse Anesthetist - CR in Seaside, OR Accepting Medicare

3 Nurse Anesthetist - CR nurses found. Showing 1 - 3

James John Wilkinson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 725 S Wahanna Rd, Seaside, OR 97138 Phone: 503-717-7000

Gregory John Pigeon, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 725 S Wahanna Rd, Seaside, OR 97138 Phone: 503-717-7000

Kenneth C Carey, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 725 S Wahanna Rd, Seaside, OR 97138 Phone: 503-717-7462    Fax: 503-717-7476

News Archive

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.

Penn study suggests future precision medicine approach to treating diabetes, other metabolic disorders

In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.

Research finding could lead to development of vaccine and therapies for mucormycosis

Mucormycosis is a deadly infection that strikes people with weakened immune systems when certain types of fungi, called Mucorales, invade the patients' cells. A novel protein on the surface of the Mucorales cells, called CotH, makes this invasion possible.

Study finds evidence on preventive interventions for cognitive decline and dementia

A new report published by the National Academies of Sciences, Engineering, and Medicine shows evidence supporting three interventions—cognitive training, blood pressure management for people with hypertension, and increased physical activity, which might slow down cognitive decline and the onset of dementia.

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease.

Read more Medical News

› Verified 7 days ago